chr16-11548144-A-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBS1BS2

The NM_001136472.2(LITAF):​c.*1493T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00522 in 454,138 control chromosomes in the GnomAD database, including 54 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.013 ( 46 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 8 hom. )

Consequence

LITAF
NM_001136472.2 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.996

Publications

1 publications found
Variant links:
Genes affected
LITAF (HGNC:16841): (lipopolysaccharide induced TNF factor) Lipopolysaccharide is a potent stimulator of monocytes and macrophages, causing secretion of tumor necrosis factor-alpha (TNF-alpha) and other inflammatory mediators. This gene encodes lipopolysaccharide-induced TNF-alpha factor, which is a DNA-binding protein and can mediate the TNF-alpha expression by direct binding to the promoter region of the TNF-alpha gene. The transcription of this gene is induced by tumor suppressor p53 and has been implicated in the p53-induced apoptotic pathway. Mutations in this gene cause Charcot-Marie-Tooth disease type 1C (CMT1C) and may be involved in the carcinogenesis of extramammary Paget's disease (EMPD). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2014]
LITAF Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 1C
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • Charcot-Marie-Tooth disease
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 16-11548144-A-C is Benign according to our data. Variant chr16-11548144-A-C is described in ClinVar as [Benign]. Clinvar id is 317755.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0125 (1910/152344) while in subpopulation AFR AF = 0.0441 (1834/41566). AF 95% confidence interval is 0.0424. There are 46 homozygotes in GnomAd4. There are 884 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1910 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LITAFNM_001136472.2 linkc.*1493T>G 3_prime_UTR_variant Exon 4 of 4 ENST00000622633.5 NP_001129944.1 Q99732-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LITAFENST00000622633.5 linkc.*1493T>G 3_prime_UTR_variant Exon 4 of 4 1 NM_001136472.2 ENSP00000483114.1 Q99732-1
LITAFENST00000339430.9 linkc.*1493T>G 3_prime_UTR_variant Exon 4 of 4 1 ENSP00000340118.5 Q99732-1
LITAFENST00000571688.6 linkc.*1493T>G 3_prime_UTR_variant Exon 4 of 4 1 ENSP00000459533.1 Q99732-1
LITAFENST00000413364.6 linkc.*1618T>G 3_prime_UTR_variant Exon 5 of 5 2 ENSP00000397958.2 Q99732-3

Frequencies

GnomAD3 genomes
AF:
0.0125
AC:
1904
AN:
152226
Hom.:
46
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0441
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00373
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00248
AC:
323
AN:
130462
AF XY:
0.00168
show subpopulations
Gnomad AFR exome
AF:
0.0428
Gnomad AMR exome
AF:
0.00214
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000402
Gnomad OTH exome
AF:
0.00175
GnomAD4 exome
AF:
0.00152
AC:
459
AN:
301794
Hom.:
8
Cov.:
0
AF XY:
0.00105
AC XY:
181
AN XY:
171996
show subpopulations
African (AFR)
AF:
0.0422
AC:
361
AN:
8554
American (AMR)
AF:
0.00187
AC:
51
AN:
27274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
10786
East Asian (EAS)
AF:
0.00
AC:
0
AN:
9210
South Asian (SAS)
AF:
0.0000671
AC:
4
AN:
59650
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
12364
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1150
European-Non Finnish (NFE)
AF:
0.0000315
AC:
5
AN:
158764
Other (OTH)
AF:
0.00271
AC:
38
AN:
14042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
34
68
102
136
170
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0125
AC:
1910
AN:
152344
Hom.:
46
Cov.:
32
AF XY:
0.0119
AC XY:
884
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.0441
AC:
1834
AN:
41566
American (AMR)
AF:
0.00373
AC:
57
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68034
Other (OTH)
AF:
0.00568
AC:
12
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
96
191
287
382
478
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00594
Hom.:
5
Bravo
AF:
0.0143
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Charcot-Marie-Tooth disease type 1C Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Benign
11
DANN
Benign
0.79
PhyloP100
1.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77423500; hg19: chr16-11642000; API